Hitesh Soni, Ph.D., MBA

Hitesh Soni, Ph.D., MBA has extensive experience in the field of biotechnology. Hitesh began their career in 2004 as an Associate Research Scientist at Zydus Cadila where they contributed to small molecule discovery for bleeding disorders and renal anemia. In 2011, they joined The University of Tennessee Health Science Center as a Research Instructor, where they performed piglet and rodent surgery, blood pressure measurement, GFR measurement, primary cell culture, calcium imaging, cell proliferation and apoptosis kinetics, arterial myography, in vivo myogenic tone measurement, ELISA, and more. Hitesh also received a young investigator award for contribution in cardio-renal research and a maturation grant award for a patent. In 2019, they began working at Renascent Biosciences Inc. as a Principal Scientist (Renal Fibrosis Lead), where they developed gene therapy-based interventions to treat kidney fibrosis from target selection to candidate development using advanced drug screening methods. In 2021, they joined Flagship Pioneering as a Principal Scientist, Translational Portfolio and a Senior Scientist, Translational Sciences, where they developed vaccine-like drugs for life-style and other chronic diseases and leveraged the immune system to treat non-immune diseases using novel concepts of vaccinology. Currently, Hitesh Soni is a Principal Scientist, Immunology at Tectonic Therapeutic, Inc., a biotech company based in Watertown, MA, where they are transforming the discovery of antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs).

Hitesh Soni, Ph.D., MBA has a diverse educational background. Hitesh obtained a Bachelor of Pharmacy from The Maharaja Sayajirao University of Baroda in 2002. Hitesh then went on to receive a Master's degree in Pharmacology from the same university in 2004. In 2007, they completed their PhD in Cardiovascular Pharmacology from L.M. College Of Pharmacy. Most recently, they earned a Master of Business Administration - MBA Professional from The University of Memphis in 2019.